Conditions: date of analysis · Homopeptide. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping…
coa
Page 20 of 33 · 771 questions tagged coa.
I have been through one internal appeal already and would like to do the next one properly. I want to understand what this actually establishes, as opposed to what it…
Conditions: ecnoglutide · four weeks · 25 °C. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like…
What I am working with: VendorInvestigate · ecnoglutide. I want a method I can write down and repeat, not a rule of thumb. I would rather over-engineer this than…
Concretely: list of related substances · MKM. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan I…
For reference: 97.9% · a wide-pore C18 column · mazdutide. I want to understand what this actually establishes, as opposed to what it is being used to imply. My…
What I am working with: retatrutide · eight weeks · 37 °C. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not…
What I am working with: orforglipron · 95.2%. I have worked this out and I would like someone to find the error, because I suspect there is one. My working so far,…
Details up front: cagrilintide · six weeks · room temperature. This is a planning question. I know what my options are; I do not know how to weigh them. What I want…
Conditions: 97.9% · VendorInvestigate · 99.4%. I have two candidate explanations and no way to distinguish them. The same procedure has worked without incident…
Setup, so nobody has to ask: a residual-solvent screen · a GLP-1 receptor agonist. I suspect the honest answer is that it depends, in which case I would like to know…
Setup, so nobody has to ask: chromatogram · GL Biochem. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a…
Details up front: CPC · Shanghai Wibson Biotechnology. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know…
Conditions: 96.8% · a C4 column · retatrutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
What I have: 99.1% · Janoshik · 96.4%. I have a result I cannot explain, and I would rather diagnose it than guess. I have checked the obvious explanations and…
Concretely: 97.6% · a C4 column · orforglipron. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
Conditions: QSC · Nantong Guangyuan Chemical. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain either…
The particulars: QST · tirzepatide. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at one. Can anyone…
The pharmacy is accredited and I have verified that on the accreditor register. I have read the primary source rather than the summary, which has left me with more…
What I am working with: VendorInvestigate · survodutide. I have read the obvious sources and they disagree with each other, so I would rather ask people who have…
For reference: 96.8% · PeptideMeter · 96.4%. An unexpected observation, and I would like a differential rather than reassurance. The conditions were within what I…
Setup, so nobody has to ask: orforglipron · two weeks · 37 °C. I am trying to build something sustainable rather than something thorough that I will abandon. I have…
What I am working with: 98.2% · sampling plan. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
I am comparing a supplier certificate against an independent result on the same lot. I am trying to build something sustainable rather than something thorough that I…